High-Tech Surgical Tools Hold Promise Despite Complexity – Circulation
This article was originally published in The Gray Sheet
Executive Summary
The surgical community's interest in minimally invasive coronary procedures will continue to provide medical device companies with a wealth of opportunities to develop new, innovative products, according to a leading cardiac surgeon
You may also be interested in...
Intuitive Surgical’s New da Vinci Indications To Grow Sales By 40% In 2005
Expanded indications and premium-priced accessories for Intuitive Surgical's da Vinci robotic surgery system will drive a sales growth of at least 40% to $194 mil. by year-end, according to the company
Cardica’s Pooled Anastomosis Device Data Fail To Connect With FDA Panel
Cardica, Inc.'s PAS Port proximal anastomosis device has appeal as a less invasive alternative to suturing for coronary bypass surgery, but the firm lacks sufficient data to demonstrate safety and effectiveness, FDA's Circulatory System Devices Panel members agreed April 22
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”